SYNB vs. THNR ETF Comparison

Comparison of Putnam BioRevolution ETF (SYNB) to Amplify Weight Loss Drug & Treatment ETF (THNR)
SYNB

Putnam BioRevolution ETF

SYNB Description

Putnam BioRevolution ETF is an exchange traded fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the public equity markets. It invests in stocks of companies operating across healthcare, pharmaceuticals, biotechnology, life sciences and biology revolution sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. Putnam BioRevolution ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$31.43

Average Daily Volume

202

Number of Holdings *

9

* may have additional holdings in another (foreign) market
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$25.97

Average Daily Volume

7,926

Number of Holdings *

7

* may have additional holdings in another (foreign) market
Performance
Period SYNB THNR
30 Days 1.53% 2.70%
60 Days 8.36%
90 Days 1.44%
12 Months 13.90%
2 Overlapping Holdings
Symbol Grade Weight in SYNB Weight in THNR Overlap
LLY B 3.78% 15.58% 3.78%
TMO D 7.45% 4.72% 4.72%
Compare ETFs